Fluicell AB
FLUI | ST
Overview
Corporate Details
- ISIN(s):
- SE0010831321 (+1 more)
- LEI:
- 549300R9LVFVFDTW5Y96
- Country:
- Sweden
- Address:
- Flöjelbergsgatan 8c, 431 37 Mölndal
- Website:
- https://fluicell.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Fluicell AB is a biotechnology company specializing in single-cell biology and high-precision tissue engineering. The company develops solutions for regenerative medicine and drug screening through its groundbreaking Nexocyte™ platform, which is based on its patented, high-resolution Biopixlar™ single-cell bioprinting technology. Fluicell's primary focus is creating precision-engineered, transplantable tissues to treat diseases with significant unmet needs, with an initial goal to develop a cure for type 1 diabetes. In parallel, the Nexocyte platform generates advanced tissue models for pharmaceutical partners to enhance drug screening, particularly for cardiac and kidney toxicity. The company also commercializes a portfolio of research tools, including the BioPen® and Dynaflow® systems, that support single-cell research globally.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Fluicell AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Fluicell AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Fluicell AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
